About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT02061826

Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)

The purpose of the study is to establish drug-induced liver injury databases in China, make criteria for Chinese drug-induced liver injury patients and evaluate the application of certain circulating ...

Lead sponsor: Beijing Ditan Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Wen Xie, master

CONTACT

Sponsors

Lead Sponsor

Beijing Ditan Hospital

Firstly, this study collects some retrospective data. Analyse these data and establish certain unique diagnostic criteria for Chinese. Then collect prospective data and validate the criteria. Otherwise,collect blood sample or other sample of the patients and study certain miRNA in diagnosis or treatment of drug-induced liver injury.

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Males and females between the age of 18 to 70 years
•Women in child-bearing period taking some contraception measures
•Patients with onset of acute liver injury attributed to antituberculosis drugs or antineoplastic drugs, Roussel Uclaf Causality Assessment Method（RUCAM ） score≥6
•Written informed consent can be obtained, some patients agree with liver biopsy

Exclusion Criteria

•Viral hepatitis
•Alcoholic liver disease or non-alcoholic liver disease
•Wilson's disease or other inherited metabolic liver diseases
•Auto-immune liver diseases
•Any dysfunction of liver
•Malnutrition
•Chronic diseases such as HIV,severe heart diseases, severe brain diseases or chronic kidney diseases
•Patients who can not complete follow-ups on time

Related studies

Active Not RecruitingNA

Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure

NCT06872372 · Acute Liver Failure, Drug-Induced Liver Injury

TERMINATEDPhase 2

Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose

NCT05517668 · Acetaminophen, Drug Overdose, and more

COMPLETEDPhase 3

Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis

NCT03100786 · Tuberculosis, Tuberculous Meningitis, and more

Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients

NCT03211208 · Drug-Induced Liver Injury, Anti-Tuberculous Drug Reaction, and more

A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects

NCT06019936 · Drug-Induced Liver Injury, Cholestatic Liver Injury, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 19, 2014Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment800

Start dateMay 2014

Last updatedFeb 19, 2014

Condition

Drug-induced Liver Injury

Locations shown

Beijing Ditan Hospital

Beijing

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 19, 2014Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions